Nazareno, Melodia L.
HRN: 22-92-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/24/2023
05/08/2023
IV
1.5grams
Q6hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes